Unraveling the regulatory connections between two controllers of breast cancer cell fate

Nucleic Acids Research

Volumn 42, Issue 11, 2014, Pages 6839-6849

  Lee, Jinho ^a,b   Tiwari, Abhinav ^b   Shum, Victor ^a,c   Mills, Gordon B ^a   Mancini, Michael A ^d   Igoshin, Oleg A ^b   Balázsi, Gábor ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Rice University   (United States)

^c University of Houston   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; TRANSCRIPTION FACTOR GATA 3;

ARTICLE; AUTOREGULATION; BREAST CANCER CELL LINE; CANCER GROWTH; CELL FATE; CELL POPULATION; CONTROLLED STUDY; HOMEOSTASIS; HUMAN; HUMAN CELL; MATHEMATICAL MODEL; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SINGLE CELL ANALYSIS;

BREAST NEOPLASMS; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; FEEDBACK, PHYSIOLOGICAL; FEMALE; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; MODELS, GENETIC;

EID: 84903149344     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku360     Document Type: Article

References (71)

1. Baĺazsi, G., van Oudenaarden, A. and Collins, J.J. (2011) Cellular decision making and biological noise: From microbes to mammals. Cell, 144, 910-925.
2. Ptashne, M. (2004) A genetic switch : Phage lambda revisited. 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
3. Novick, A. and Weiner, M. (1957) Enzyme induction as an all-or-none phenomenon. Proc. Natl. Acad. Sci. U.S.A., 43, 553-566.
4. Narula, J., Devi, S.N., Fujita, M. and Igoshin, O.A. (2012) Ultrasensitivity of the bacillus subtilis sporulation decision. Proc. Natl. Acad. Sci. U.S.A., 109, E3513-E3522.
5. Acar, M., Becskei, A. and van Oudenaarden, A. (2005) Enhancement of cellular memory by reducing stochastic transitions. Nature, 435, 228-232.
6. Singh, A., Razooky, B., Cox, C.D., Simpson, M.L. and Weinberger, L.S. (2010) Transcriptional bursting from the HIV-1 promoter is a significant source of stochastic noise in HIV-1 gene expression. Biophys. J., 98, L32-L34.
7. Kalmar, T., Lim, C., Hayward, P., Munoz-Descalzo, S., Nichols, J., Garcia-Ojalvo, J. and Martinez Arias, A. (2009) Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. PLoS. Biol., 7, e1000149.
8. Narula, J., Williams, C.J., Tiwari, A., Marks-Bluth, J., Pimanda, J.E. and Igoshin, O.A. (2013) Mathematical model of a gene regulatory network reconciles effects of genetic perturbations on hematopoietic stem cell emergence. Dev. Biol., 379, 258-269.
9. Brock, A., Chang, H. and Huang, S. (2009) Non-genetic heterogeneity-a mutation-independent driving force for the somatic evolution of tumours. Nat. Rev. Genet., 10, 336-342.
10. Marusyk, A., Almendro, V. and Polyak, K. (2012) Intra-tumour heterogeneity: A looking glass for cancer? Nat. Rev. Cancer, 12, 323-334.
11. Weinstein, J.N., Collisson, E.A., Mills, G.B., Shaw, K.R., Ozenberger, B.A., Ellrott, K., Shmulevich, I., Sander, C. and Stuart, J.M. (2013) The cancer genome atlas pan-cancer analysis project. Nat. Genet., 45, 1113-1120.
12. Akavia, U.D., Litvin, O., Kim, J., Sanchez-Garcia, F., Kotliar, D., Causton, H.C., Pochanard, P., Mozes, E., Garraway, L.A. and Pe'er, D. (2010) An integrated approach to uncover drivers of cancer. Cell, 143, 1005-1017.
13. Sharma, S.V., Lee, D.Y., Li, B., Quinlan, M.P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M.A. et al. (2010) A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell, 141, 69-80.
14. LaMarca, H.L. and Rosen, J.M. (2007) Estrogen regulation of mammary gland development and breast cancer: Amphiregulin takes center stage. Breast Cancer Res., 9, 304.
15. Fisher, B., Redmond, C., Fisher, E.R. and Caplan, R. (1988) Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: Findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J. Clin. Oncol., 6, 1076-1087.
16. Roodi, N., Bailey, L.R., Kao, W.Y., Verrier, C.S., Yee, C.J., Dupont, W.D. and Parl, F.F. (1995) Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J. Natl. Cancer Inst., 87, 446-451.
17. Takemoto, N., Arai, K. and Miyatake, S. (2002) Cutting edge: The differential involvement of the N-finger of GATA-3 in chromatin remodeling and transactivation during Th2 development. J. Immunol., 169, 4103-4107.
18. LaMarca, H.L. and Rosen, J.M. (2008) Minireview: Hormones and mammary cell fate-what will I become when I grow up? Endocrinology, 149, 4317-4321.
19. Kouros-Mehr, H., Kim, J.W., Bechis, S.K. and Werb, Z. (2008) GATA-3 and the regulation of the mammary luminal cell fate. Curr. Opin. Cell Biol., 20, 164-170.
20. Asselin-Labat, M.L., Sutherland, K.D., Barker, H., Thomas, R., Shackleton, M., Forrest, N.C., Hartley, L., Robb, L., Grosveld, F.G., van der Wees, J. et al. (2007) Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol., 9, 201-209.
21. Hoch, R.V., Thompson, D.A., Baker, R.J. and Weigel, R.J. (1999) GATA-3 is expressed in association with estrogen receptor in breast cancer. Int. J. Cancer, 84, 122-128.
22. Mehra, R., Varambally, S., Ding, L., Shen, R., Sabel, M.S., Ghosh, D., Chinnaiyan, A.M. and Kleer, C.G. (2005) Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Res., 65, 11259-11264.
23. Kouros-Mehr, H., Bechis, S.K., Slorach, E.M., Littlepage, L.E., Egeblad, M., Ewald, A.J., Pai, S.Y., Ho, I.C. and Werb, Z. (2008) GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell, 13, 141-152.
24. Sorlie, T., Perou, C.M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S. et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U.S.A., 98, 10869-10874.
25. Dydensborg, A.B., Rose, A.A., Wilson, B.J., Grote, D., Paquet, M., Giguere, V., Siegel, P.M. and Bouchard, M. (2009) GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis. Oncogene, 28, 2634-2642.
26. Yan, W., Cao, Q.J., Arenas, R.B., Bentley, B. and Shao, R. (2010) GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition. J. Biol. Chem., 285, 14042-14051.
27. Chou, J., Lin, J.H., Brenot, A., Kim, J.W., Provot, S. and Werb, Z. (2013) GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression. Nat. Cell Biol., 15, 201-213.
28. Eeckhoute, J., Keeton, E.K., Lupien, M., Krum, S.A., Carroll, J.S. and Brown, M. (2007) Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res., 67, 6477-6483.
29. Marconett, C.N., Sundar, S.N., Poindexter, K.M., Stueve, T.R., Bjeldanes, L.F. and Firestone, G.L. (2010) Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER)alpha protein degradation in breast cancer cells disrupting an ERalpha-GATA3 transcriptional cross-regulatory loop. Mol. Biol. Cell, 21, 1166-1177.
30. Metivier, R., Penot, G., Hubner, M.R., Reid, G., Brand, H., Kos, M. and Gannon, F. (2003) Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell, 115, 751-763.
31. Ong, C.T. and Corces, V.G. (2011) Enhancer function: New insights into the regulation of tissue-specific gene expression.Nat. Rev. Genet., 12, 283-293.
32. Gonzalez-Angulo, A.M., Hennessy, B.T., Meric-Bernstam, F., Sahin, A., Liu, W., Ju, Z., Carey, M.S., Myhre, S., Speers, C., Deng, L. et al. (2011) Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer. Clin. Proteomics, 8, 11.
33. Hartig, S.M., Newberg, J.Y., Bolt, M.J., Szafran, A.T., Marcelli, M. and Mancini, M.A. (2011) Automated microscopy and image analysis for androgen receptor function. Methods Mol. Biol., 776, 313-331.
34. Tiwari, A. and Igoshin, O.A. (2012) Coupling between feedback loops in autoregulatory networks affects bistability range, open-loop gain and switching times. Phys. Biol., 9, 055003.
35. Wolffe, A.P. (2001) Chromatin remodeling: Why it is important in cancer. Oncogene, 20, 2988-2990.
36. Kos, M., Reid, G., Denger, S. and Gannon, F. (2001) Minireview: Genomic organization of the human ERalpha gene promoter region. Mol. Endocrinol., 15, 2057-2063.
37. Troester, M.A., Herschkowitz, J.I., Oh, D.S., He, X., Hoadley, K.A., Barbier, C.S. and Perou, C.M. (2006) Gene expression patterns associated with p53 status in breast cancer. BMC Cancer, 6, 276.
38. Rosenfeld, N., Elowitz, M.B. and Alon, U. (2002) Negative autoregulation speeds the response times of transcription networks. J. Mol. Biol., 323, 785-793.
39. Dauvois, S., White, R. and Parker, M.G. (1993) The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J. Cell Sci., 106(Pt 4), 1377-1388.
40. Reid, G., Hubner, M.R., Metivier, R., Brand, H., Denger, S., Manu, D., Beaudouin, J., Ellenberg, J. and Gannon, F. (2003) Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol. Cell, 11, 695-707.
41. Gordon, A.J., Halliday, J.A., Blankschien, M.D., Burns, P.A., Yatagai, F. and Herman, C. (2009) Transcriptional infidelity promotes heritable phenotypic change in a bistable gene network. PLoS Biol., 7, e44.
42. Kaufmann, B.B., Yang, Q., Mettetal, J.T. and van Oudenaarden, A. (2007) Heritable stochastic switching revealed by single-cell genealogy. PLoS Biol., 5, e239.
43. Acar, M., Mettetal, J.T. and van Oudenaarden, A. (2008) Stochastic switching as a survival strategy in fluctuating environments. Nat. Genet., 40, 471-475.
44. Kramer, B.P., Viretta, A.U., Daoud-El-Baba, M., Aubel, D., Weber, W. and Fussenegger, M. (2004) An engineered epigenetic transgene switch in mammalian cells. Nat. Biotechnol., 22, 867-870.
45. Tiwari, A., Ray, J.C., Narula, J. and Igoshin, O.A. (2011) Bistable responses in bacterial genetic networks: Designs and dynamical consequences. Math. Biosci., 231, 76-89.
46. Veening, J.W., Smits, W.K. and Kuipers, O.P. (2008) Bistability, epigenetics, and bet-hedging in bacteria. Annu. Rev. Microbiol., 62, 193-210.
47. Elowitz, M.B., Levine, A.J., Siggia, E.D. and Swain, P.S. (2002) Stochastic gene expression in a single cell. Science, 297, 1183-1186.
48. Kaern, M., Elston, T.C., Blake, W.J. and Collins, J.J. (2005) Stochasticity in gene expression: From theories to phenotypes. Nat. Rev. Genet., 6, 451-464.
49. Blake, W.J., Kaern, M., Cantor, C.R. and Collins, J.J. (2003) Noise in eukaryotic gene expression. Nature, 422, 633-637.
50. Blake, W.J., Baĺazsi, G., Kohanski, M.A., Isaacs, F.J., Murphy, K.F., Kuang, Y., Cantor, C.R., Walt, D.R. and Collins, J.J. (2006) Phenotypic consequences of promoter-mediated transcriptional noise. Mol. Cell, 24, 853-865.
51. Elf, J. and Ehrenberg, M. (2003) Fast evaluation of fluctuations in biochemical networks with the linear noise approximation. Genome Res., 13, 2475-2484.
52. Alves, R. and Savageau, M.A. (2000) Extending the method of mathematically controlled comparison to include numerical comparisons. Bioinformatics, 16, 786-798.
53. Pfeuty, B. and Kaneko, K. (2009) The combination of positive and negative feedback loops confers exquisite flexibility to biochemical switches. Phys. Biol., 6, 046013.
54. Ferrell, J.E. Jr. (2002) Self-perpetuating states in signal transduction: Positive feedback, double-negative feedback and bistability. Curr. Opin. Cell Biol., 14, 140-148.
55. Tyson, J.J., Albert, R., Goldbeter, A., Ruoff, P. and Sible, J. (2008) Biological switches and clocks. J. R. Soc. Interface, 5(Suppl. 1), S1-S8.
56. Yao, G., Lee, T.J., Mori, S., Nevins, J.R. and You, L. (2008) A bistable Rb-E2F switch underlies the restriction point.Nat. Cell Biol., 10, 476-482.
57. Tan, C., Marguet, P. and You, L. (2009) Emergent bistability by a growth-modulating positive feedback circuit. Nat. Chem. Biol., 5, 842-848.
58. Lee, J., Lee, J., Farquhar, K.S., Yun, J., Frankenberger, C.A., Bevilacqua, E., Yeung, K., Kim, E.J., Baĺazsi, G. and Rosner, M.R. (2014) Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions. Proc. Natl. Acad. Sci. U.S.A., 111, E364-373.
59. Laganiere, J., Deblois, G., Lefebvre, C., Bataille, A.R., Robert, F. and Giguere, V. (2005) Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc. Natl. Acad. Sci. U.S.A., 102, 11651-11656.
60. Eeckhoute, J., Carroll, J.S., Geistlinger, T.R., Torres-Arzayus, M.I. and Brown, M. (2006) A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes Dev., 20, 2513-2526.
61. Kong, S.L., Li, G., Loh, S.L., Sung, W.K. and Liu, E.T. (2011) Cellular reprogramming by the conjoint action of ERalpha, FOXA1, and GATA3 to a ligand-inducible growth state. Mol. Syst. Biol., 7, 526.
62. Kouros-Mehr, H., Slorach, E.M., Sternlicht, M.D. and Werb, Z. (2006) GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell, 127, 1041-1055.
63. Ross-Innes, C.S., Stark, R., Teschendorff, A.E., Holmes, K.A., Ali, H.R., Dunning, M.J., Brown, G.D., Gojis, O., Ellis, I.O., Green, A.R. et al. (2012) Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature, 481, 389-393.
64. Augello, M.A., Hickey, T.E. and Knudsen, K.E. (2011) FOXA1: Master of steroid receptor function in cancer. EMBO J., 30, 3885-3894.
65. McKenna, N.J., Xu, J., Nawaz, Z., Tsai, S.Y., Tsai, M.J. and O'Malley, B.W. (1999) Nuclear receptor coactivators: Multiple enzymes, multiple complexes, multiple functions. J. Steroid Biochem. Mol. Biol., 69, 3-12.
66. Brandman, O. and Meyer, T. (2008) Feedback loops shape cellular signals in space and time. Science, 322, 390-395.
67. Nawaz, Z., Lonard, D.M., Dennis, A.P., Smith, C.L. and O'Malley, B.W. (1999) Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl. Acad. Sci. U.S.A., 96, 1858-1862.
68. Tiwari, A., Baĺazsi, G., Gennaro, M.L. and Igoshin, O.A. (2010) The interplay of multiple feedback loops with post-translational kinetics results in bistability of mycobacterial stress response. Phys. Biol., 7, 036005.
69. Gardner, T.S., di Bernardo, D., Lorenz, D. and Collins, J.J. (2003) Inferring genetic networks and identifying compound mode of action via expression profiling. Science, 301, 102-105.
70. Veiga, D.F., Dutta, B. and Baĺazsi, G. (2010) Network inference and network response identification: Moving genome-scale data to the next level of biological discovery. Mol. Biosyst., 6, 469-480.
71. Ma, W.Z., Trusina, A., El-Samad, H., Lim, W.A. and Tang, C. (2009) Defining network topologies that can achieve biochemical adaptation. Cell, 138, 760-773.